Insight from convergent validity of assessment of systemic sclerosis–associated Raynaud phenomenon with nailfold capillaroscopy
Krishnasai Abhishek Madathanapalli, Areeka Memon, Manvitha Nadella, Kyra Shelton, Michael Zamani, Amrita Makhijani, Alyssa Williams, Ilayda Gunes, Sophia Esme Kujawski, William Odell, Stephanie Perez, Nicolas Page, Lucy Duran Camacho, Cassandra Van Horn, Francis Perry Wilson

TL;DR
This study shows that a questionnaire for Raynaud phenomenon in systemic sclerosis correlates with nailfold capillaroscopy findings, supporting its validity.
Contribution
The study provides new evidence for the construct validity of the ASRAP questionnaire in systemic sclerosis patients.
Findings
Female patients reported higher ASRAP scores compared to males.
Nailfold capillaroscopy abnormalities like dilated capillaries and capillary dropout correlated with higher ASRAP scores.
The correlation between ASRAP and NFC was stronger in winter months.
Abstract
The assessment of systemic sclerosis–associated Raynaud phenomenon (ASRAP) questionnaire was recently developed. We tested the convergent validity of the ASRAP instrument with patient demographics and capillary morphology on nailfold capillaroscopy (NFC). Participants completed the ASRAP (range 20–80; higher scores unfavourable) and underwent NFC using Dinolite™. We collected demographic and relevant clinical data. Two blinded assessors classified NFC images as ‘scleroderma pattern’ present or absent and recorded specific abnormalities. We assigned the NFC semi-quantitative score (range 0–3) based on the frequency of these abnormalities. Descriptive statistics were generated, and regression and correlation analyses were used to evaluate associations between ASRAP, NFC and clinical factors. Seventy-five patients [87% women, 78% white, 77% with limited cutaneous SSc] with a mean (SD)…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSystemic Sclerosis and Related Diseases · Dermatologic Treatments and Research
